Haptoglobin glycoforms in a case of carbohydrate-deficient glycoprotein syndrome

被引:15
|
作者
Ferens-Sieczkowska, M
Midro, A
Mierzejewska-Iwanowska, B
Zwierz, K
Katnik-Prastowska, I
机构
[1] Wroclaw Med Univ, Dept Chem & Immunochem, PL-50345 Wroclaw, Poland
[2] Med Acad, Inst Chem, Pharmaceut Biochem Div, PL-15222 Bialystok, Poland
[3] Med Acad, Inst Obstet & Gynaecol, Div Genet, PL-15222 Bialystok, Poland
关键词
carbohydrate-deficient glycoprotein syndrome; CDGS; haptoglobin; acute phase protein; N-glycosylation; glycoforms;
D O I
10.1023/A:1007078114674
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alterations in haptoglobin (Hp) glycosylation were examined in the plasma of the first patient with carbohydrate-deficient glycoprotein syndrome (CDGS) who was described in Poland. Hp concentration in the CDGS patient plasma was low (240 mg/l) and the Hp phenotype was shown to be 2-2. Three glycoforms of the Hp beta subunit were observed in SDS-PAGE in CDGS. The densitometric analysis and molecular weight determinations suggested that 50% of glycoforms were fully glycosylated; 30% contained three out of four and 20% only two out of four glycan units compared to those that are present in Hp derived from healthy people. Results with lectins (concanavalin A and Sambucus nigra, Maackia amurensis and Alleuria aurantia agglutinins) indicate that all three glycoforms of beta subunit of CDGS-Hp contained biantennary complex glycans terminated with alpha 2,6 bound sialic acid, but without fucose or alpha 2,3 linked sialic acid. Hp glycosylation abnormalities described in this work suggest that this case was a type I carbohydrate-deficient glycoprotein syndrome.
引用
收藏
页码:573 / 577
页数:5
相关论文
共 50 条
  • [41] Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose
    Hendriksz, CJ
    McClean, P
    Henderson, MJ
    Keir, DG
    Worthington, VC
    Imtiaz, F
    Schollen, E
    Matthijs, G
    Winchester, BG
    ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 85 (04) : 339 - 340
  • [42] Alteration of mannose transport in fibroblasts from type I carbohydrate deficient glycoprotein syndrome patients
    Dupre, T
    Ogier-Denis, E
    Moore, SEH
    Cormier-Daire, V
    Dehoux, M
    Durand, G
    Seta, N
    Codogno, P
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1999, 1453 (03): : 369 - 377
  • [43] The analysis of carbohydrate-deficient transferrin, marker of chronic alcoholism, using capillary electrophoresis
    Wuyts, B
    Delanghe, JR
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (06) : 739 - 746
  • [44] Determination of carbohydrate-deficient transferrin separated by lectin affinity chromatography for detecting chronic alcohol abuse
    Yoshikawa, K
    Umetsu, K
    Shinzawa, H
    Yuasa, I
    Maruyama, K
    Ohkura, T
    Yamashita, K
    Suzuki, T
    FEBS LETTERS, 1999, 458 (02) : 112 - 116
  • [46] CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME TYPE-II - AN AUTOSOMAL RECESSIVE N-ACETYLGLUCOSAMINYLTRANSFERASE-II DEFICIENCY DIFFERENT FROM TYPICAL HEREDITARY ERYTHROBLASTIC MULTINUCLEARITY, WITH A POSITIVE ACIDIFIED-SERUM LYSIS TEST (HEMPAS)
    CHARUK, JHM
    TAN, J
    BERNARDINI, M
    HADDAD, S
    REITHMEIER, RAF
    JAEKEN, J
    SCHACHTER, H
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 230 (02): : 797 - 805
  • [47] A1/A2 blood group variant due to fucosylation deficiency in carbohydrate deficient glycoprotein syndrome type I?
    Heyne, K
    Weidinger, S
    EUROPEAN JOURNAL OF PEDIATRICS, 1999, 158 (02) : 170 - 170
  • [48] A1/A2 blood group variant due to fucosylation deficiency in carbohydrate deficient glycoprotein syndrome type I ?
    K. Heyne
    S. Weidinger
    European Journal of Pediatrics, 1999, 158 : 170 - 170
  • [49] Abnormal surface expression of sialoglycans on B lymphocyte cell lines from patients with carbohydrate deficient glycoprotein syndrome I A (CDGS I A)
    Bergmann, M
    Gross, HJ
    Abdelatty, F
    Möller, P
    Jaeken, J
    Schwartz-Albiez, R
    GLYCOBIOLOGY, 1998, 8 (10) : 963 - 972
  • [50] HPLC evaluation of clinical and pharmacological factors reported to cause false-positive carbohydrate-deficient transferrin (CDT) levels
    Bergstrom, Jonas P.
    Helander, Anders
    CLINICA CHIMICA ACTA, 2008, 389 (1-2) : 164 - 166